Tuesday news reports: March 17, 2009

There are four reports in today’s news of any real interest to the patient community. They deal with:

  • The progress of the Prostate Cancer Clinical Trials Consortium
  • Antiandrogens in prevention of prostate cancer (maybe)
  • Disseminated tumor cells and prostate cancer progression
  • Oral fenretinide in treatment of biochemical relapse after first-line therapy … READ MORE …

Disseminated tumor cells and risk for prostate cancer recurrence

It has long been known that men with apparently localized prostate cancer can relapse many years after radical prostatectomy and/or other forms of treatment that appear to have been curative. A new study from researchers at the University of Washington appears to throw some more light on why this may occur. … READ MORE …